# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | CP-91149 | 1 | Solubility | 22.9 | uM | ALA3301364 | nM | |||||
2. | CP-91149 | 1 | PPB | 97.81 | % | ALA3301365 | % | |||||
3. | CP-91149 | 1 | PPB | 97.32 | % | ALA3301366 | % | |||||
4. | CP-91149 | 1 | LogD7.4 | 3.6 | ALA3301363 | |||||||
5. | CP-91149 | 1 | inhibition | = | -0.06 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
6. | CP-91149 | 1 | Inhibition | = | -3.021 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | CP-91149 | 1 | inhibition | = | -0.06 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
8. | CP-91149 | 1 | inhibition | = | -10.9 | % | ALA4808150 | % | Homo sapiens | |||
9. | CP-91149 | 1 | inhibition | = | -19.33 | % | ALA4808149 | % | Homo sapiens | |||
10. | CP-91149 | 1 | Inhibition | = | 7.81 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
11. | CP-91149 | 1 | IC50 | = | 3172.5 | nM | ALA4624438 | 5.50 | nM | Rattus norvegicus | ||
12. | CP-91149 | 1 | IC50 | = | 3310.4 | nM | ALA4624437 | 5.48 | nM | Homo sapiens | ||
13. | CP-91149 | 1 | IC50 | = | 92.2 | nM | ALA4624436 | 7.04 | nM | |||
14. | CP-91149 | 1 | solubility | < | 1 | mg/ml | ALA4624435 | ug.mL-1 | ||||
15. | CP-91149 | 1 | IC50 | = | 110 | nM | ALA4624434 | 6.96 | nM | |||
16. | CP-91149 | 1 | IC50 | = | 0.082 | uM | ALA3861188 | 7.09 | nM | Homo sapiens | ||
17. | CP-91149 | 1 | MIC | > | 128 | ug ml-1 | ALA5104868 | ug.mL-1 | Staphylococcus aureus | |||
18. | CP-91149 | 1 | MIC | > | 128 | ug ml-1 | ALA5104867 | ug.mL-1 | Staphylococcus aureus | |||
19. | CP-91149 | 1 | MIC | > | 128 | ug ml-1 | ALA5104866 | ug.mL-1 | Staphylococcus aureus | |||
20. | CP-91149 | 1 | MIC | = | 32 | ug ml-1 | ALA5104865 | ug.mL-1 | Staphylococcus aureus |